Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Iovance Biotherapeutics, Inc. (IOVA) shares are trading higher on Thursday morning. The shares have been gaining since Wednesday as the company announced that it will continue with the first potential biologics license application for lifileucel, as it received regulatory feedback from FDA.


RTTNews | May 20, 2021 11:09AM EDT

11:08 Thursday, May 20, 2021 (RTTNews.com) - Iovance Biotherapeutics, Inc. (IOVA) shares are trading higher on Thursday morning. The shares have been gaining since Wednesday as the company announced that it will continue with the first potential biologics license application for lifileucel, as it received regulatory feedback from FDA.

Currently, shares are at $19.10, up 16.84 percent from the previous close of $16.33 on a volume of 19,178,567. For the 52-week period, the shares have traded in a range of $15.88-$54.21 on average volume of 2,791,350.

Read the original article on RTTNews ( https://www.rttnews.com/3196477/stock-alert-iovance-biotherapeutics-up-16.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC